Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
出版年份 2020 全文链接
标题
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
作者
关键词
-
出版物
Pharmacological Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-20
DOI
10.1007/s43440-020-00134-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy
- (2020) Nalinda B. Wasala et al. MOLECULAR THERAPY
- Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy
- (2020) A. Moretti et al. NATURE MEDICINE
- Long‐term human IgG treatment improves heart and muscle function in a mouse model of Duchenne muscular dystrophy
- (2020) Jana Zschüntzsch et al. Journal of Cachexia Sarcopenia and Muscle
- Viltolarsen: First Approval
- (2020) Sohita Dhillon DRUGS
- Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks
- (2020) Brigida Boccanegra et al. PHARMACOLOGICAL RESEARCH
- Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy
- (2020) Jerry R. Mendell et al. JAMA Neurology
- Lack of miR-378 attenuates muscular dystrophy in mdx mice
- (2020) Paulina Podkalicka et al. JCI Insight
- rAAVrh74.MCK.GALGT2 Protects Against Loss of Hemodynamic Function in the Aging mdx Mouse Heart
- (2019) Rui Xu et al. MOLECULAR THERAPY
- Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial
- (2019) Michael Taylor et al. NEUROLOGY
- Inhibition of MicroRNA-92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy-related phenotype in mdx mice
- (2019) Mayank Verma et al. MUSCLE & NERVE
- Development of Novel Micro-dystrophins with Enhanced Functionality
- (2019) Julian N. Ramos et al. MOLECULAR THERAPY
- Morpholino‐induced exon skipping stimulates cell‐mediated and humoral responses to dystrophin in mdx mice
- (2019) Maria Candida Vila et al. JOURNAL OF PATHOLOGY
- The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
- (2019) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells
- (2019) J Manuel Pioner et al. CARDIOVASCULAR RESEARCH
- Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias
- (2019) Rocco Romagnuolo et al. Stem Cell Reports
- miR-378a influences vascularization in skeletal muscles
- (2019) Bart Krist et al. CARDIOVASCULAR RESEARCH
- Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function
- (2019) Eric P. Hoffman et al. NEUROLOGY
- miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
- (2019) Iwona Bronisz-Budzyńska et al. Skeletal Muscle
- Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
- (2019) Yafeng Song et al. NATURE MEDICINE
- Lack of Heme Oxygenase-1 Induces Inflammatory Reaction and Proliferation of Muscle Satellite Cells after Cardiotoxin-Induced Skeletal Muscle Injury
- (2018) Magdalena Kozakowska et al. AMERICAN JOURNAL OF PATHOLOGY
- Critical View on Mesenchymal Stromal Cells in Regenerative Medicine
- (2018) Agnieszka Langrzyk et al. ANTIOXIDANTS & REDOX SIGNALING
- Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice
- (2018) Katarzyna Pietraszek-Gremplewicz et al. ANTIOXIDANTS & REDOX SIGNALING
- Genetic Lineage Tracing of Sca-1+Cells Reveals Endothelial but Not Myogenic Contribution to the Murine Heart
- (2018) Ronald J. Vagnozzi et al. CIRCULATION
- Muscular Dystrophies
- (2018) John C. Carter et al. CLINICS IN CHEST MEDICINE
- The progress of AAV-mediated gene therapy in neuromuscular disorders
- (2018) Sara Aguti et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
- (2018) David J Birnkrant et al. LANCET NEUROLOGY
- Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy
- (2018) Dongsheng Duan MOLECULAR THERAPY
- Autologous Cell Therapy Approach for Duchenne Muscular Dystrophy using PiggyBac Transposons and Mesoangioblasts
- (2018) Pavithra S. Iyer et al. MOLECULAR THERAPY
- Human embryonic stem cell–derived cardiomyocytes restore function in infarcted hearts of non-human primates
- (2018) Yen-Wen Liu et al. NATURE BIOTECHNOLOGY
- Nutrition in Duchenne muscular dystrophy 16–18 March 2018, Zaandam, the Netherlands
- (2018) Ingrid E.C. Verhaart et al. NEUROMUSCULAR DISORDERS
- Role of miR-200c in Myogenic Differentiation Impairment via p66Shc: Implication in Skeletal Muscle Regeneration of Dystrophic mdx Mice
- (2018) Marco D’Agostino et al. Oxidative Medicine and Cellular Longevity
- Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
- (2018) Yu Zhang et al. PHYSIOLOGICAL REVIEWS
- Expression profiling of disease progression in canine model of Duchenne muscular dystrophy
- (2018) Candice Brinkmeyer-Langford et al. PLoS One
- Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes
- (2018) Eric P. Hoffman et al. STEROIDS
- Direct Reprogramming of Mouse Fibroblasts into Functional Skeletal Muscle Progenitors
- (2018) Ori Bar-Nur et al. Stem Cell Reports
- Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy
- (2018) Mark A. Aminzadeh et al. Stem Cell Reports
- Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure
- (2018) Leslie W. Miller et al. JAMA Cardiology
- Undeniable Evidence That the Adult Mammalian Heart Lacks an Endogenous Regenerative Stem Cell
- (2018) Bryan D. Maliken et al. CIRCULATION
- Strategies for controlling CRISPR/Cas9 off-target effects and biological variations in mammalian genome editing experiments
- (2018) Michelle L. Kimberland et al. JOURNAL OF BIOTECHNOLOGY
- Clear up this stem-cell mess
- (2018) Douglas Sipp et al. NATURE
- Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug
- (2018) Laurie S. Conklin et al. PHARMACOLOGICAL RESEARCH
- Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
- (2018) Leonela Amoasii et al. SCIENCE
- CRISPR Correction of Duchenne Muscular Dystrophy
- (2018) Yi-Li Min et al. Annual Review of Medicine
- Profiling proliferative cells and their progeny in damaged murine hearts
- (2018) Kai Kretzschmar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Establishment of stably expandable induced myogenic stem cells by four transcription factors
- (2018) Eun-Joo Lee et al. Cell Death & Disease
- Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study
- (2018) John P Bourke et al. BMJ Open
- A current approach to heart failure in Duchenne muscular dystrophy
- (2017) Domenico D’Amario et al. HEART
- Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy
- (2017) Mattia Quattrocelli et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced serum myostatin concentrations associated with genetic muscle disease progression
- (2017) Peter M. Burch et al. JOURNAL OF NEUROLOGY
- Pre-clinical evaluation of N -acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy
- (2017) Gavin J. Pinniger et al. JOURNAL OF PHYSIOLOGY-LONDON
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Craig M McDonald et al. LANCET
- Progress toward Gene Therapy for Duchenne Muscular Dystrophy
- (2017) Joel R. Chamberlain et al. MOLECULAR THERAPY
- A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
- (2017) Ronald G. Victor et al. NEUROLOGY
- Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy
- (2017) Yusuke Echigoya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Marketing of unproven stem cell–based interventions: A call to action
- (2017) Douglas Sipp et al. Science Translational Medicine
- Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
- (2017) Virginie Mariot et al. Nature Communications
- Eteplirsen in the treatment of Duchenne muscular dystrophy
- (2017) Kenji Rowel Lim et al. Drug Design Development and Therapy
- Using computer simulation models to investigate the most promising microRNAs to improve muscle regeneration during ageing
- (2017) Carole J. Proctor et al. Scientific Reports
- Direct reprogramming of fibroblasts into skeletal muscle progenitor cells by transcription factors enriched in undifferentiated subpopulation of satellite cells
- (2017) Naoki Ito et al. Scientific Reports
- Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
- (2017) Tahnee L. Kennedy et al. Skeletal Muscle
- The golden retriever model of Duchenne muscular dystrophy
- (2017) Joe N. Kornegay Skeletal Muscle
- A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy
- (2017) Chady H. Hakim et al. Molecular Therapy-Methods & Clinical Development
- Functional improvement of dystrophic muscle by repression of utrophin: let-7c interaction
- (2017) Manoj K. Mishra et al. PLoS One
- Enhanced autophagy as a potential mechanism for the improved physiological function by simvastatin in muscular dystrophy
- (2016) Nicholas P. Whitehead Autophagy
- A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells
- (2016) Courtney S. Young et al. Cell Stem Cell
- Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
- (2016) Agnieszka Loboda et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Duchenne Muscular Dystrophy Mice and Men
- (2016) Jill A. Rafael-Fortney et al. CIRCULATION RESEARCH
- Exon skipping: a first in class strategy for Duchenne muscular dystrophy
- (2016) Erik H. Niks et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo
- (2016) Nelly Béchir et al. FASEB JOURNAL
- Inherited heart disease - what can we expect from the second decade of human iPS cell research?
- (2016) Milena Bellin et al. FEBS LETTERS
- Approving a Problematic Muscular Dystrophy Drug
- (2016) Aaron S. Kesselheim et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial)
- (2016) Tarun Chakravarty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dystrophin-Deficient Cardiomyopathy
- (2016) Forum Kamdar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials
- (2016) Sripal Bangalore et al. MAYO CLINIC PROCEEDINGS
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- No longer going to waste
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Eteplirsen therapy for Duchenne muscular dystrophy: skipping to the front of the line
- (2016) James J. Dowling Nature Reviews Neurology
- Histological effects of givinostat in boys with Duchenne muscular dystrophy
- (2016) Paolo Bettica et al. NEUROMUSCULAR DISORDERS
- miR-378a-3p promotes differentiation and inhibits proliferation of myoblasts by targeting HDAC4 in skeletal muscle development
- (2016) Xuefeng Wei et al. RNA Biology
- Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors
- (2016) Yoshitsugu Aoki et al. Drug Design Development and Therapy
- Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts
- (2016) David W. Hammers et al. Journal of the American Heart Association
- Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy
- (2016) Janelle M. Spinazzola et al. Expert Opinion on Orphan Drugs
- Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
- (2016) Bailey Miskew Nichols et al. Jove-Journal of Visualized Experiments
- Myopathy in older people receiving statin therapy: a systematic review and meta-analysis
- (2015) Roli B. Iwere et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Contemporary Cardiac Issues in Duchenne Muscular Dystrophy: Table.
- (2015) Elizabeth M. McNally et al. CIRCULATION
- Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy
- (2015) G. Cossu et al. EMBO Molecular Medicine
- Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases
- (2015) Magdalena Tertil et al. FREE RADICAL BIOLOGY AND MEDICINE
- Second-generation compound for the modulation of utrophin in the therapy of DMD
- (2015) Simon Guiraud et al. HUMAN MOLECULAR GENETICS
- The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
- (2015) Catherine L. Bladen et al. HUMAN MUTATION
- Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy
- (2015) Jana Zschüntzsch et al. JOURNAL OF NEUROCHEMISTRY
- Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial
- (2015) Subha V Raman et al. LANCET NEUROLOGY
- Combination Antisense Treatment for Destructive Exon Skipping of Myostatin and Open Reading Frame Rescue of Dystrophin in Neonatal mdx Mice
- (2015) Ngoc B Lu-Nguyen et al. MOLECULAR THERAPY
- A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
- (2015) Jerry R Mendell et al. MOLECULAR THERAPY
- Current Understanding of Molecular Pathology and Treatment of Cardiomyopathy in Duchenne Muscular Dystrophy
- (2015) Tirsa van Westering et al. MOLECULES
- Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection
- (2015) Mónica Anaya-Segura et al. MOLECULES
- Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: Management and lessons learned
- (2015) Francesca Iodice et al. NEUROMUSCULAR DISORDERS
- A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy
- (2015) Nicholas P. Whitehead et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
- (2015) C. Long et al. SCIENCE
- In vivo gene editing in dystrophic mouse muscle and muscle stem cells
- (2015) M. Tabebordbar et al. SCIENCE
- In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
- (2015) C. E. Nelson et al. SCIENCE
- HO-1/CO system in tumor growth, angiogenesis and metabolism — Targeting HO-1 as an anti-tumor therapy
- (2015) Agnieszka Loboda et al. VASCULAR PHARMACOLOGY
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
- (2015) Hongmei Lisa Li et al. Stem Cell Reports
- Partial restoration of cardiac function with PDZ nNOS in aged mdx model of Duchenne cardiomyopathy
- (2014) Y. Lai et al. HUMAN MOLECULAR GENETICS
- Human Skeletal Muscle–derived CD133+ Cells Form Functional Satellite Cells After Intramuscular Transplantation in Immunodeficient Host Mice
- (2014) Jinhong Meng et al. MOLECULAR THERAPY
- Ataluren treatment of patients with nonsense mutation dystrophinopathy
- (2014) Katharine Bushby et al. MUSCLE & NERVE
- PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy
- (2014) M. D. Nelson et al. NEUROLOGY
- Microtubule binding distinguishes dystrophin from utrophin
- (2014) J. J. Belanto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA
- (2014) C. Long et al. SCIENCE
- A PiggyBac-mediated approach for muscle gene transfer or cell therapy
- (2014) Déborah Ley et al. Stem Cell Research
- Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
- (2014) Yusuke Echigoya et al. Nucleic Acid Therapeutics
- Interplay Between Heme Oxygenase-1 and miR-378 Affects Non-Small Cell Lung Carcinoma Growth, Vascularization, and Metastasis
- (2013) Klaudia Skrzypek et al. ANTIOXIDANTS & REDOX SIGNALING
- Heme Oxygenase-1 Is Required for Angiogenic Function of Bone Marrow-Derived Progenitor Cells: Role in Therapeutic Revascularization
- (2013) Anna Grochot-Przeczek et al. ANTIOXIDANTS & REDOX SIGNALING
- Angiogenic Impairment of the Vascular Endothelium
- (2013) Mariangela Palladino et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
- (2013) Christopher R. Heier et al. EMBO Molecular Medicine
- All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy
- (2013) Gernot Schram et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Unknown
- (2013) Silvia Consalvi et al. MOLECULAR MEDICINE
- Statin-Induced Rhabdomyolysis: A Comprehensive Review of Case Reports
- (2013) Polyana Mendes et al. Physiotherapy Canada
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
- (2013) Richard S. Finkel et al. PLoS One
- An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells
- (2013) Antonio Filareto et al. Nature Communications
- Muscular effects of statins in the elderly female: a review
- (2013) Eric Schneider et al. Clinical Interventions in Aging
- Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy
- (2012) Laurence Viollet et al. AMERICAN JOURNAL OF CARDIOLOGY
- Angiotensin II-Induced Production of Mitochondrial Reactive Oxygen Species: Potential Mechanisms and Relevance for Cardiovascular Disease
- (2012) Sergey I. Dikalov et al. ANTIOXIDANTS & REDOX SIGNALING
- Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice
- (2012) Agnieszka Jazwa et al. CARDIOVASCULAR RESEARCH
- Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice
- (2012) Radbod Darabi et al. Cell Stem Cell
- Interference with Myostatin/ActRIIB Signaling as a Therapeutic Strategy for Duchenne Muscular Dystrophy
- (2012) Helge Amthor et al. CURRENT GENE THERAPY
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Statins on Skeletal Muscle
- (2012) Beth A. Parker et al. EXERCISE AND SPORT SCIENCES REVIEWS
- Combined Effect of AAV-U7-Induced Dystrophin Exon Skipping and Soluble Activin Type IIB Receptor in mdx Mice
- (2012) Willem M.H. Hoogaars et al. HUMAN GENE THERAPY
- Left ventricular assist device in Duchenne Cardiomyopathy: Can we change the natural history of cardiac disease?
- (2012) Antonio Amodeo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy
- (2012) Jong-Hee Kim et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Sildenafil reduces respiratory muscle weakness and fibrosis in the mdx mouse model of Duchenne muscular dystrophy
- (2012) Justin M Percival et al. JOURNAL OF PATHOLOGY
- Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial
- (2012) Raj R Makkar et al. LANCET
- Gene and cell-mediated therapies for muscular dystrophy
- (2012) Patryk Konieczny et al. MUSCLE & NERVE
- Induced pluripotent stem cells: the new patient?
- (2012) Milena Bellin et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment
- (2012) Corinne Betts et al. Molecular Therapy-Nucleic Acids
- Heme Oxygenase-1 Inhibits Myoblast Differentiation by Targeting Myomirs
- (2011) Magdalena Kozakowska et al. ANTIOXIDANTS & REDOX SIGNALING
- Therapeutic approaches to muscular dystrophy
- (2011) A. Goyenvalle et al. HUMAN MOLECULAR GENETICS
- MicroRNA-378 Targets the Myogenic Repressor MyoR during Myoblast Differentiation
- (2011) Jeffrey Gagan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle
- (2011) Sanjeewa A. Goonasekera et al. JOURNAL OF CLINICAL INVESTIGATION
- SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice
- (2011) Jin-Hong Shin et al. Journal of Translational Medicine
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- N-Acetylcysteine treatment of dystrophic mdx mice results in protein thiol modifications and inhibition of exercise induced myofibre necrosis
- (2011) Jessica R. Terrill et al. NEUROMUSCULAR DISORDERS
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
- (2011) Catherine Moorwood et al. PLoS One
- Stem Cell-Mediated Transfer of a Human Artificial Chromosome Ameliorates Muscular Dystrophy
- (2011) F. S. Tedesco et al. Science Translational Medicine
- Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy
- (2010) Vinod Malik et al. ANNALS OF NEUROLOGY
- Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
- (2010) Igor Nudelman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Overexpression of SERCA1a in the mdx Diaphragm Reduces Susceptibility to Contraction-Induced Damage
- (2010) Kevin J. Morine et al. HUMAN GENE THERAPY
- Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin
- (2010) D. Li et al. JOURNAL OF CELL SCIENCE
- Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells
- (2010) Francesco Saverio Tedesco et al. JOURNAL OF CLINICAL INVESTIGATION
- Combination of Myostatin Pathway Interference and Dystrophin Rescue Enhances Tetanic and Specific Force in Dystrophic mdx Mice
- (2010) Julie Dumonceaux et al. MOLECULAR THERAPY
- Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
- (2010) Joe N Kornegay et al. MOLECULAR THERAPY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
- (2010) A. R. Amenta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment
- (2010) C. Colussi et al. Proteomics Clinical Applications
- Overexpression of Galgt2 Reduces Dystrophic Pathology in the Skeletal Muscles of Alpha Sarcoglycan-Deficient Mice
- (2009) Rui Xu et al. AMERICAN JOURNAL OF PATHOLOGY
- Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy
- (2009) Yi Lai et al. JOURNAL OF CLINICAL INVESTIGATION
- Skeletal muscle stem cells in developmental versus regenerative myogenesis
- (2009) S. Tajbakhsh JOURNAL OF INTERNAL MEDICINE
- In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study
- (2009) Elisa Negroni et al. MOLECULAR THERAPY
- Blastocyst Injection of Embryonic Stem Cells: A Simple Approach to Unveil Mechanisms of Corrections in Mouse Models of Human Disease
- (2009) Joel S. Schneider et al. Stem Cell Reviews and Reports
- Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice
- (2008) Paul T. Martin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
- Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities
- (2008) Agnieszka Loboda et al. ANTIOXIDANTS & REDOX SIGNALING
- Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: A magnetic resonance imaging study
- (2008) Sophie Mavrogeni et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy
- (2008) E. Kimura et al. HUMAN MOLECULAR GENETICS
- Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function
- (2008) HaiFang Yin et al. HUMAN MOLECULAR GENETICS
- N-Acetylcysteine ameliorates skeletal muscle pathophysiology inmdxmice
- (2008) Nicholas P. Whitehead et al. JOURNAL OF PHYSIOLOGY-LONDON
- Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle
- (2008) DeWayne Townsend et al. MOLECULAR THERAPY
- HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
- (2008) C. Colussi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Janus face of Nrf2–HO-1 axis in cancer—Friend in chemoprevention, foe in anticancer therapy
- (2007) Agnieszka Loboda et al. LUNG CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started